Developmental Research Program

发展项目计划资助具有发展潜力的早期研究项目 更多实质性的研究项目。其目标是在以下领域促进创新研究 转化为开发新的疫苗、疗法和/或诊断方法，以对抗A-C类 选定的病原体或其他新出现的传染病病原体。发展项目计划投资于 最有潜力争夺传统国立卫生研究院(NIH)资金的倡议 将提供长达24个月的项目支助，年度预算在100,000美元至100,000美元之间 直接成本12.5万美元。其目的是为“高风险”研究提供资金，需要的初步数据比 常规R01赠款。该方案还试图以新颖的方法吸引第二地区的调查人员， 他们目前可能不在生物防御领域工作。 发展项目计划鼓励参与BASIC的研究人员之间的合作 和临床微生物学研究以及其他免疫学、细胞生物学、化学生物学和 生物信息学。为了创造最肥沃的发现环境，战略投资将被引导到 具有高回报潜力和很有可能获得未来美国国立卫生研究院资助的新项目。

The Developmental Projects Program funds early-stage research projects with the potential to develop into more substantial research programs. Its objective is to promote innovative research in areas that can translate into the development of new vaccines, therapeutics and/or diagnostics to combat Category A-C select agents or other emerging infectious pathogens. The Developmental Projects Program invests in initiatives having the greatest potential to compete for traditional National Institutes of Health (NIH) funding Project support will be provided for up to 24 months, with an annual budget between $100,000 and $125,000 in direct costs. The intent is to fund "higher-risk" research, requiring less preliminary data than a conventional R01 grant. The Program also seeks to attract Region II investigators with novel approaches, who may not presently be working in the area of biodefense. The Developmental Projects Program encourages collaborations among investigators involved in basic and clinical microbiology research and others in immunology, cell biology, chemical biology, and bioinformatics. To create the most fertile environment for discovery, strategic investments will be directed to novel projects with the potential for high return and a good probability of qualifying for future NIH funding.